In March 2015, a new Irish company made its stock market debut in Dublin. Malin Corporation was set up to invest in promising biotechnology start-ups emerging from the transatlantic stream of deals and innovation between the US and Ireland. The company has claimed that its listing was “one of Europe’s largest-ever life sciences IPOs”. Malin grew out of an existing firm, Brandon Point Industries (BPI), and its founders’ ambition to build on their existing investments to go bigger – and go public. To prepare for their €300 million IPO, they hired Davy as adviser and broker. The admission prospectus circulated…

Join The Currency

Special offer: Full annual membership for just €200.

Don’t miss out on what is going on with our daily unique stories from our team of skilled journalists and insightful commentators.

Members of The Currency get full access to over 1,500 exclusive interviews, investigations, and analysis, plus over 75 podcasts.

Annual membership is just €200 for the first year, a saving of €100.

Or try The Currency for the first month for just €5, a saving of €20.

Cancel at any time.

To become a member today click here.